Table 4.
Axon loss, 6 weeks | Axon loss, 12 weeks | RGC layer loss, 6 weeks | RGC layer loss, 12 weeks | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Strain | N | mean ± SD | median | N | mean ± SD | median | N | mean ± SD | median | N | mean ± SD | median |
CD1 | 10 | 12.9 ± 11.8%† | 12.0% | 10 | 32.0 ± 28.3%† | 25.2% | 10 | 9.9 ± 9.5%† | 10.4% | 10 | 20.1 ± 15.7% † | 15.1% |
C57BL/6 younger | 14 | 15.9 ± 23.5%† | 9.3% | 10 | 6.5 ± 8.9%* | 6.5% | 14 | 9.3 ± 6.5%† | 9.0% | 10 | 5.2 ± 12.1% | 6.9% |
DBA/2J | 11 | 7.1 ± 7.6%† | 7.3% | 13 | 13.9 ± 27.8% | 4.8% | 12 | 9.1 ± 7.4%† | 9.1% | 12 | 4.1 ± 16.5% | 1.6% |
C57BL/6 older | 12 | 10.5 ± 19.6% | 5.4% | 12 | 0.1 ± 8.2% | −0.3% | 12 | 0.0 ± 6.7% | −0.3% | 12 | 4.1 ± 7.3% | 2.4% |
Sample number (N), standard deviation (SD).
p < 0.05,
p < 0.01 for difference between injected and fellow eye, t test.